HLS

HLS Therapeutics

• Dow Jones·08/14 15:59

  HLS Therapeutics Inc Price Target Raised to C$8.00/Share From C$7.00 by Raymond James

• Dow Jones·08/14 15:59

  HLS Therapeutics Inc Raised to Strong Buy From Outperform by Raymond James

• Dow Jones·08/13 15:58

  HLS Therapeutics Inc Raised to Buy From Hold by Canaccord Genuity

• Dow Jones·08/12 10:32

  *HLS Therapeutics 2Q Loss/Shr 3c >HLS.T

• Dow Jones·08/12 10:32

  *HLS Therapeutics 2Q Rev $14.7M >HLS.T

• Dow Jones·08/12 10:30

  Press Release: HLS Therapeutics Announces Q2 2026 -2-

• Dow Jones·08/12 10:30

  Press Release: HLS Therapeutics Announces Q2 2026 Financial Results

• Dow Jones·06/26 21:00

  Press Release: HLS Therapeutics Reports Annual Meeting Results

• Dow Jones·06/23 11:14

  HLS Therapeutics Gets TSX Green Light to Buy Back up to 8% of Public Float

• Dow Jones·06/23 11:04

  *HLS Therapeutics May Buy Back Up to 1.5M Shrs Under Program

• Dow Jones·06/23 11:00

  Press Release: HLS Therapeutics Announces Normal Course Issuer Bid

• Dow Jones·05/15 11:03

  *HLS Therapeutics Still Sees 2026 Adjusted Ebitda $18.5M-$21M >HLS.T

• Dow Jones·05/15 11:02

  *HLS Therapeutics Backs 2026 View of Rev $56M-$60M >HLS.T

• Dow Jones·05/15 11:00

  Press Release: HLS Therapeutics Announces Q1 2026 -2-

• Dow Jones·05/15 11:00

  Press Release: HLS Therapeutics Announces Q1 2026 Financial Results